230
Views
26
CrossRef citations to date
0
Altmetric
Original Research

An algorithm for identification and classification of individuals with type 1 and type 2 diabetes mellitus in a large primary care database

, , &
Pages 373-380 | Published online: 12 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tra My Pham, James R Carpenter, Tim P Morris, Manuj Sharma & Irene Petersen. (2019) Ethnic Differences in the Prevalence of Type 2 Diabetes Diagnoses in the UK: Cross-Sectional Analysis of the Health Improvement Network Primary Care Database. Clinical Epidemiology 11, pages 1081-1088.
Read now
Manuj Sharma, Irwin Nazareth & Irene Petersen. (2019) Observational studies of treatment effectiveness: worthwhile or worthless?. Clinical Epidemiology 11, pages 35-42.
Read now

Articles from other publishers (23)

Aaron J. Deutsch, Lauren Stalbow, Timothy D. Majarian, Josep M. Mercader, Alisa K. Manning, Jose C. Florez, Ruth J.F. Loos & Miriam S. Udler. (2023) Polygenic Scores Help Reduce Racial Disparities in Predictive Accuracy of Automated Type 1 Diabetes Classification Algorithms. Diabetes Care 46:4, pages 794-800.
Crossref
Nicholas J. Thomas, Andrew McGovern, Katherine G. Young, Seth A. Sharp, Michael N. Weedon, Andrew T. Hattersley, John Dennis & Angus G. Jones. (2023) Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches. Journal of Clinical Epidemiology 153, pages 34-44.
Crossref
Zhe Xu, Matthew Arnold, Luanluan Sun, David Stevens, Ryan Chung, Samantha Ip, Jessica Barrett, Stephen Kaptoge, Lisa Pennells, Emanuele Di Angelantonio & Angela M Wood. (2022) Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records. International Journal of Epidemiology 51:6, pages 1813-1823.
Crossref
Sushma Jaiswal & Tarun Jaiswal. (2022) Machine Learning-Based Classification Models for Diagnosis of Diabetes. Recent Advances in Computer Science and Communications 15:6.
Crossref
Juan Carlos Bazo-Alvarez, Kingshuk Pal, Tra My Pham, Irwin Nazareth, Irene Petersen & Manuj Sharma. (2021) Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice. Scientific Reports 11:1.
Crossref
Zhe Xu, Matthew Arnold, David Stevens, Stephen Kaptoge, Lisa Pennells, Michael J Sweeting, Jessica Barrett, Emanuele Di Angelantonio & Angela M Wood. (2021) Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment. American Journal of Epidemiology 190:10, pages 2000-2014.
Crossref
Joanna Ling, Digsu Koye, Luke Buizen, Kamlesh Khunti, Olga Montvida & Sanjoy K. Paul. (2021) Temporal trends in co‐morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK . Diabetes, Obesity and Metabolism 23:5, pages 1150-1161.
Crossref
Y.-M.M. Park, D.B. Bookwalter, K.M. O'Brien, C.L. Jackson, C.R. Weinberg & D.P. Sandler. (2021) A prospective study of type 2 diabetes, metformin use, and risk of breast cancer. Annals of Oncology 32:3, pages 351-359.
Crossref
Seungwon Lee, Chelsea Doktorchik, Elliot Asher Martin, Adam Giles D'Souza, Cathy Eastwood, Abdel Aziz Shaheen, Christopher Naugler, Joon Lee & Hude Quan. (2021) Electronic Medical Record–Based Case Phenotyping for the Charlson Conditions: Scoping Review. JMIR Medical Informatics 9:2, pages e23934.
Crossref
Calvin Ke, Thérèse A. Stukel, Andrea Luk, Baiju R. Shah, Prabhat Jha, Eric Lau, Ronald C. W. Ma, Wing-Yee So, Alice P. Kong, Elaine Chow & Juliana C. N. Chan. (2020) Development and validation of algorithms to classify type 1 and 2 diabetes according to age at diagnosis using electronic health records. BMC Medical Research Methodology 20:1.
Crossref
Digsu N. Koye, Joanna Ling, John Dibato, Kamlesh Khunti, Olga Montvida & Sanjoy K. Paul. (2020) Temporal Trend in Young-Onset Type 2 Diabetes—Macrovascular and Mortality Risk: Study of U.K. Primary Care Electronic Medical Records. Diabetes Care 43:9, pages 2208-2216.
Crossref
Alanna Weisman, Karen Tu, Jacqueline Young, Matthew Kumar, Peter C Austin, Liisa Jaakkimainen, Lorraine Lipscombe, Ronnie Aronson & Gillian L Booth. (2020) Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada. BMJ Open Diabetes Research & Care 8:1, pages e001224.
Crossref
Dafin F. Muresanu, Aruna Sharma, Seaab Sahib, Z. Ryan Tian, Lianyuan Feng, Ala Nozari, José Vicente Lafuente, Anca D. Buzoianu, Per-Ove Sjöquist, Ranjana Patnaik, Lars Wiklund & Hari Shanker Sharma. 2020. Neuropharmacology of Neuroprotection. Neuropharmacology of Neuroprotection 285 367 .
Manuj Sharma, Irwin Nazareth & Irene Petersen. (2019) Comparative effectiveness of sitagliptin vs sulphonylureas in older people. Age and Ageing 48:5, pages 725-732.
Crossref
R. Thayakaran, M. Perrins, K. M. Gokhale, S. Kumaran, P. Narendran, M. J. Price, K. Nirantharakumar & K. A. Toulis. (2019) Impact of glycaemic control on fracture risk in 5368 people with newly diagnosed Type 1 diabetes: a time‐dependent analysis. Diabetic Medicine 36:8, pages 1013-1019.
Crossref
Tra My Pham, James R Carpenter, Tim P Morris, Angela M Wood & Irene Petersen. (2018) Population‐calibrated multiple imputation for a binary/categorical covariate in categorical regression models. Statistics in Medicine 38:5, pages 792-808.
Crossref
Sameer Al-Ghamdi, Gulfam Ahmad, Ali Hassan Ali, Nasraddin Bahakim, Salman Alomran, Waleed Alhowikan, Salman Almutairi, Tariq Basalem & Faisal Aljuaid. (2018) RETRACTED ARTICLE: Al Kharj diabetic patients’ perception about diabetes mellitus using revised-illness perception questionnaire (IPQ-R). BMC Family Practice 19:1.
Crossref
Sharon Saydah & Giuseppina Imperatore. (2018) Emerging Approaches in Surveillance of Type 1 Diabetes. Current Diabetes Reports 18:9.
Crossref
Ellie Paige, Jessica Barrett, David Stevens, Ruth H Keogh, Michael J Sweeting, Irwin Nazareth, Irene Petersen & Angela M Wood. (2018) Landmark Models for Optimizing the Use of Repeated Measurements of Risk Factors in Electronic Health Records to Predict Future Disease Risk. American Journal of Epidemiology 187:7, pages 1530-1538.
Crossref
Krishnarajah Nirantharakumar, Nuredin Mohammed, Konstantinos A. Toulis, G. Neil Thomas & Parth Narendran. (2018) Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis. Diabetologia 61:5, pages 1064-1070.
Crossref
Iain M. Carey, Julia A. CritchleyStephen DeWildeTess HarrisFay J. HoskingDerek G. Cook. (2018) Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study. Diabetes Care 41:3, pages 513-521.
Crossref
Marilyn T. Wan, Daniel B. Shin, Rebecca A. Hubbard, Megan H. Noe, Nehal N. Mehta & Joel M. Gelfand. (2018) Psoriasis and the risk of diabetes: A prospective population-based cohort study. Journal of the American Academy of Dermatology 78:2, pages 315-322.e1.
Crossref
Nicholas J. Thomas, Andrew McGovern, Katherine Young, Seth A. Sharp, Michael N. Weedon, Andrew Hattersley, John Dennis & Angus G. Jones. (2022) Identifying Type 1 and 2 Diabetes in Population Level Data: Assessing the Accuracy of Published Approaches. SSRN Electronic Journal.
Crossref